Stem cell and its derivatives as drug delivery vehicles: an effective new strategy of drug delivery system

References

• Almeida CR, Caires HR, Vasconcelos DP, Barbosa MA. 2016. NAP-2 Secreted by human NK cells can stimulate mesenchymal stem/stromal cell recruitment. Stem Cell Rep. 6(4):466–473. doi:10.1016/j.stemcr.2016.02.012.
   Web of Science ®Google Scholar
• Almeida-Porada G, Atala AJ, Porada CD. 2020. Therapeutic mesenchymal stromal cells for immunotherapy and for gene and drug delivery. Mol Ther Methods Clin Dev. 16:204–224. doi:10.1016/j.omtm.2020.01.005.
   PubMed Web of Science ®Google Scholar
• An L, Wang Y, Lin J, Tian Q, Xie Y, Hu J, et al. 2019. Macrophages-mediated delivery of small gold nanorods for tumor hypoxia photoacoustic imaging and enhanced photothermal therapy. ACS Appl Mater Interfaces. 11(17):15251–15261. doi:10.1021/acsami.9b00495.
   PubMed Web of Science ®Google Scholar
• Bagheri E, Abnous K, Farzad SA, Taghdisi SM, Ramezani M, Alibolandi M. 2020. Targeted doxorubicin-loaded mesenchymal stem cells-derived exosomes as a versatile platform for fighting against colorectal cancer. Life Sci. 261:118369. doi:10.1016/j.lfs.2020.118369.
   PubMed Web of Science ®Google Scholar
• Banerji SK, Hayes MA. 2007. Examination of nonendocytotic bulk transport of nanoparticles across phospholipid membranes. Langmuir: ACS J Surf Colloids. 23(6):3305–3313.
   Web of Science ®Google Scholar
• Borghese C, Casagrande N, Corona G, Aldinucci D. 2020. Adipose-derived stem cells primed with paclitaxel inhibit ovarian cancer spheroid growth and overcome paclitaxel resistance. Pharmaceutics. 12(5). doi:10.3390/pharmaceutics12050401
   Web of Science ®Google Scholar
• Bose RJ, Kim BJ, Arai Y, Han IB, Moon JJ, Paulmurugan R, et al. 2018. Bioengineered stem cell membrane functionalized nanocarriers for therapeutic targeting of severe hindlimb ischemia. Biomaterials. 185:360–370. doi:10.1016/j.biomaterials.2018.08.018.
   PubMed Web of Science ®Google Scholar
• Cao S, Guo J, He Y, Alahdal M, Tang S, Zhao Y, et al. 2018. Nano-loaded human umbilical cord mesenchymal stem cells as targeted carriers of doxorubicin for breast cancer therapy. Artif Cells Nanomed Biotechnol. 46(sup1):642–652. doi:10.1080/21691401.2018.1434185.
   PubMed Web of Science ®Google Scholar
• Chastkofsky MI, Pituch KC, Katagi H, Zannikou M, Ilut L, Xiao T, et al. 2021. Mesenchymal stem cells successfully deliver oncolytic virotherapy to diffuse intrinsic pontine glioma. Clin Cancer Res. 27(6):1766–1777. doi:10.1158/1078-0432.CCR-20-1499.
   PubMed Web of Science ®Google Scholar
• Chinnappan M, Srivastava A, Amreddy N, Razaq M, Pareek V, Ahmed R, et al. 2020. Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs. Cancer Lett. 486:18–28. doi:10.1016/j.canlet.2020.05.004.
   PubMed Web of Science ®Google Scholar
• Chiu RC. 2005. ‘Stealth immune tolerance’ in stem cell transplantation: potential for ‘universal donors’ in myocardial regenerative therapy. J Heart Lung Transplant. 24(5):511–516. doi:10.1016/j.healun.2004.11.010.
   Web of Science ®Google Scholar
• Coccè V, Farronato D, Brini AT, Masia C, Giannì AB, Piovani G, et al. 2017. Drug loaded gingival mesenchymal stromal cells (GinPa-MSCs) inhibit in vitro proliferation of oral squamous cell carcinoma. Sci Rep. 7(1):9376. doi:10.1038/s41598-017-09175-4.
   PubMed Web of Science ®Google Scholar
• Danhier F. 2016. To exploit the tumor microenvironment: since the EPR effect fails in the clinic, what is the future of nanomedicine? J Control Release. 244(Pt A):108–121. doi:10.1016/j.jconrel.2016.11.015.
   PubMed Web of Science ®Google Scholar
• de Miguel-Beriain I. 2015. The ethics of stem cells revisited. Adv Drug Deliv Rev. 82–83:176–180. doi:10.1016/j.addr.2014.11.011.
   PubMed Web of Science ®Google Scholar
• de Witte SFH, Luk F, Sierra Parraga JM, Gargesha M, Merino A, Korevaar SS, et al. 2018. Immunomodulation by therapeutic mesenchymal stromal cells (MSC) is triggered through phagocytosis of MSC by monocytic cells. Stem Cells. 36(4):602–615. doi:10.1002/stem.2779.
   PubMed Web of Science ®Google Scholar
• Doherty GJ, McMahon HT. 2009. Mechanisms of endocytosis. Annu Rev Biochem. 78:857–902. doi:10.1146/annurev.biochem.78.081307.110540.
   PubMed Web of Science ®Google Scholar
• Fang J, Nakamura H, Maeda H. 2011. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 63(3):136–151. doi:10.1016/j.addr.2010.04.009.
   PubMed Web of Science ®Google Scholar
• Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI, et al. 2009. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 18(5):683–692. doi:10.1089/scd.2008.0253.
   PubMed Web of Science ®Google Scholar
• Gao C, Lin Z, Jurado-Sanchez B, Lin X, Wu Z, He Q. 2016a. Stem cell membrane-coated nanogels for highly efficient in vivo tumor targeted drug delivery. Small. 12(30):4056–4062. doi:10.1002/smll.201600624.
   PubMed Web of Science ®Google Scholar
• Gao C, Lin Z, Wu Z, Lin X, He Q. 2016b. Stem-cell-membrane camouflaging on near-infrared photoactivated upconversion nanoarchitectures for in vivo remote-controlled photodynamic therapy. ACS Appl Mater Interfaces. 8(50):34252–34260. doi:10.1021/acsami.6b12865.
   PubMed Web of Science ®Google Scholar
• Gao M, Liang C, Song X, Chen Q, Jin Q, Wang C, et al. 2017. Erythrocyte-membrane-enveloped perfluorocarbon as nanoscale artificial red blood cells to relieve tumor hypoxia and enhance cancer radiotherapy. Adv Mater. 29(35). doi:10.1002/adma.201701429.
   Web of Science ®Google Scholar
• Gozde U, Ufuk G. 2018. Smart drug delivery systems in cancer therapy. Curr Drug Targets. 19(3):202–212. doi:10.2174/1389450117666160401124624.
   Web of Science ®Google Scholar
• Gutierrez-Millan C, Calvo Díaz C, Lanao JM, Colino CI. 2021. Advances in exosomes-based drug delivery systems. Macromol Biosci. 21(1):e2000269. doi:10.1002/mabi.202000269.
   Web of Science ®Google Scholar
• Hagenhoff A, Bruns CJ, Zhao Y, von Luttichau I, Niess H, Spitzweg C, et al. 2016. Harnessing mesenchymal stem cell homing as an anticancer therapy. Expert Opin Biol Ther. 16(9):1079–1092. doi:10.1080/14712598.2016.1196179.
   PubMed Web of Science ®Google Scholar
• Haider H, Jiang S, Idris NM, Ashraf M. 2008. IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circ Res. 103(11):1300–1308. doi:10.1161/CIRCRESAHA.108.186742.
   PubMed Web of Science ®Google Scholar
• Han Y, Li X, Zhang Y, Han Y, Chang F, Ding J. 2019. Mesenchymal stem cells for regenerative medicine. Cells. 8(8). doi:10.3390/cells8080886.
   Web of Science ®Google Scholar
• Herea D-D, Labusca L, Radu E, Chiriac H, Grigoras M, Panzaru OD, et al. 2019. Human adipose-derived stem cells loaded with drug-coated magnetic nanoparticles for in-vitro tumor cells targeting. Mater Sci Eng C-Mater Biol Appl. 94:666–676. doi:10.1016/j.msec.2018.10.019.
   PubMed Web of Science ®Google Scholar
• Hong HS, Kim YH, Son Y. 2012. Perspectives on mesenchymal stem cells: tissue repair, immune modulation, and tumor homing. Arch Pharmacal Res. 35(2):201–211. doi:10.1007/s12272-012-0201-0.
   Web of Science ®Google Scholar
• Huang B, Qian J, Ma J, Huang Z, Shen Y, Chen X, et al. 2014. Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction. Stem Cell Res Ther. 5(1):22. doi:10.1186/scrt410.
   PubMedGoogle Scholar
• Huang RY, Lin YH, Lin SY, Li YN, Chiang CS, Chang CW. 2019a. Magnetic ternary nanohybrids for nonviral gene delivery of stem cells and applications on cancer therapy. Theranostics. 9(8):2411–2423. doi:10.7150/thno.29326.
   Web of Science ®Google Scholar
• Huang X, Chen H, Xie Y, Cao Z, Lin X, Wang Y. 2019b. Foxo1 Overexpression ameliorates TNF-alpha-induced oxidative damage and promotes osteogenesis of human periodontal ligament stem cells via antioxidant defense activation. Stem Cells Int. 2019:2120453. doi:10.1155/2019/2120453.
   Web of Science ®Google Scholar
• Kalimuthu S, Gangadaran P, Rajendran RL, Zhu L, Oh JM, Lee HW, et al. 2018a. A new approach for loading anticancer drugs into mesenchymal stem cell-derived exosome mimetics for cancer therapy. Front Pharmacol. 9:1116. doi:10.3389/fphar.2018.01116.
   PubMed Web of Science ®Google Scholar
• Kalimuthu S, Oh JM, Gangadaran P, Zhu L, Lee HW, Rajendran RL, et al. 2017. In vivo tracking of chemokine receptor CXCR4-engineered mesenchymal stem cell migration by optical molecular imaging. Stem Cells Int. 2017:8085637. doi:10.1155/2017/8085637.
   Web of Science ®Google Scholar
• Kalimuthu S, Zhu L, Oh JM, Gangadaran P, Lee HW, Baek SH, et al. 2018b. Migration of mesenchymal stem cells to tumor xenograft models and in vitro drug delivery by doxorubicin. Int J Med Sci. 15(10):1051–1061. doi:10.7150/ijms.25760.
   PubMed Web of Science ®Google Scholar
• Karp JM, Leng Teo GS. 2009. Mesenchymal stem cell homing: the devil Is in the details. Cell Stem Cell. 4(3):206–216. doi:10.1016/j.stem.2009.02.001.
   PubMed Web of Science ®Google Scholar
• Karp JM, Leng Teo GS. 2009. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell. 4(3):206–216. doi:10.1016/j.stem.2009.02.001.
   PubMed Web of Science ®Google Scholar
• Kerkelä E, Hakkarainen T, Mäkelä T, Raki M, Kambur O, Kilpinen L, et al. 2013. Transient proteolytic modification of mesenchymal stromal cells increases lung clearance rate and targeting to injured tissue. Stem Cells Transl Med. 2(7):510–520. doi:10.5966/sctm.2012-0187.
   Web of Science ®Google Scholar
• Kiernan CH, KleinJan A, Peeters M, Wolvius EB, Farrell E, Brama PAJ. 2018. Allogeneic chondrogenically differentiated human bone marrow stromal cells do not induce dendritic cell maturation. J Tissue Eng Regen Med. 12(6):1530–1540. doi:10.1002/term.2682.
   Web of Science ®Google Scholar
• Kolios G, Moodley Y. 2013. Introduction to stem cells and regenerative medicine. Respiration. 85(1):3–10. doi:10.1159/000345615.
   PubMed Web of Science ®Google Scholar
• Krueger TEG, Thorek DLJ, Denmeade SR, Isaacs JT, Brennen WN. 2018. Concise review: mesenchymal stem cell-based drug delivery: the good, the bad, the ugly, and the promise. Stem Cells Transl Med. 7(9):651–663. doi:10.1002/sctm.18-0024.
   PubMed Web of Science ®Google Scholar
• Layek B, Sadhukha T, Panyam J, Prabha S. 2018. Nano-engineered mesenchymal stem cells increase therapeutic efficacy of anticancer drug through true active tumor targeting. Mol Cancer Ther. 17(6):1196–1206. doi:10.1158/1535-7163.Mct-17-0682.
   PubMed Web of Science ®Google Scholar
• Layek B, Shetty M, Nethi SK, Sehgal D, Starr TK, Prabha S. 2020. Mesenchymal stem cells as guideposts for nanoparticle-mediated targeted drug delivery in ovarian cancer. Cancers (Basel). 12(4). doi:10.3390/cancers12040965.
   Web of Science ®Google Scholar
• Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, et al. 2009. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 5(1):54–63. doi:10.1016/j.stem.2009.05.003.
   PubMed Web of Science ®Google Scholar
• Leibacher J, Henschler R. 2016. Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells. Stem Cell Res Ther. 7:7. doi:10.1186/s13287-015-0271-2.
   PubMed Web of Science ®Google Scholar
• Levy O, Brennen WN, Han E, Rosen DM, Musabeyezu J, Safaee H, et al. 2016. A prodrug-doped cellular Trojan horse for the potential treatment of prostate cancer. Biomaterials. 91:140–150. doi:10.1016/j.biomaterials.2016.03.023.
   PubMed Web of Science ®Google Scholar
• Li C, Wang J, Wang Y, Gao H, Wei G, Huang Y, et al. 2019. Recent progress in drug delivery. Acta Pharmaceutica Sinica B. 9(6):1145–1162. doi:10.1016/j.apsb.2019.08.003.
   PubMed Web of Science ®Google Scholar
• Li D, Xue W, Li M, Dong M, Wang J, Wang X, et al. 2018a. VCAM-1(+) macrophages guide the homing of HSPCs to a vascular niche. Nature. 564(7734):119–124. doi:10.1038/s41586-018-0709-7.
   Web of Science ®Google Scholar
• Li L, Guan Y, Liu H, Hao N, Liu T, Meng X, et al. 2011. Silica nanorattle-doxorubicin-anchored mesenchymal stem cells for tumor-tropic therapy. ACS Nano. 5(9):7462–7470. doi:10.1021/nn202399w.
   PubMed Web of Science ®Google Scholar
• Li M, Qiu L, Hu W, Deng X, Xu H, Cao Y, et al. 2018b. Genetically-modified bone mesenchymal stem cells with TGF-beta3 improve wound healing and reduce scar tissue formation in a rabbit model. Exp Cell Res. 367(1):24–29. doi:10.1016/j.yexcr.2018.02.006.
   Web of Science ®Google Scholar
• Li Z, Fan D, Xiong D. 2015. Mesenchymal stem cells as delivery vectors for anti-tumor therapy. Stem Cell Investig. 2:6. doi:10.3978/j.issn.2306-9759.2015.03.01.
   PubMedGoogle Scholar
• Lin L, Du L. 2018. The role of secreted factors in stem cells-mediated immune regulation. Cell Immunol. 326:24–32. doi:10.1016/j.cellimm.2017.07.010.
   Web of Science ®Google Scholar
• Lisini D, Nava S, Frigerio S, Pogliani S, Maronati G, Marcianti A, et al. 2020. Automated large-scale production of paclitaxel loaded mesenchymal stromal cells for cell therapy applications. Pharmaceutics. 12:5. doi:10.3390/pharmaceutics12050411.
   Web of Science ®Google Scholar
• Luo M, Zhou Y, Gao N, Cheng W, Wang X, Cao J, et al. 2020. Mesenchymal stem cells transporting black phosphorus-based biocompatible nanospheres: active Trojan horse for enhanced photothermal cancer therapy. Chem Eng J. 385. doi:10.1016/j.cej.2019.123942.
   Web of Science ®Google Scholar
• Lv Q, Deng J, Chen Y, Wang Y, Liu B, Liu J. 2020. Engineered human adipose stem-cell-derived exosomes loaded with miR-21-5p to promote diabetic cutaneous wound healing. Mol Pharm. 17(5):1723–1733. doi:10.1021/acs.molpharmaceut.0c00177.
   PubMed Web of Science ®Google Scholar
• Ma M, Chen S, Liu Z, Xie H, Deng H, Shang S, et al. 2017. miRNA-221 of exosomes originating from bone marrow mesenchymal stem cells promotes oncogenic activity in gastric cancer. Onco Targets Ther. 10:4161–4171. doi:10.2147/OTT.S143315.
   PubMed Web of Science ®Google Scholar
• Maiti P, Peruzzaro S, Kolli N, Andrews M, Al-Gharaibeh A, Rossignol J, et al. 2019. Transplantation of mesenchymal stem cells overexpressing interleukin-10 induces autophagy response and promotes neuroprotection in a rat model of TBI. J Cell Mol Med. 23(8):5211–5224. doi:10.1111/jcmm.14396.
   PubMed Web of Science ®Google Scholar
• Majumdar MK, Keane-Moore M, Buyaner D, Hardy WB, Moorman MA, McIntosh KR, et al. 2003. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci. 10(2):228–241. doi:10.1007/bf02256058.
   Web of Science ®Google Scholar
• Marquez-Curtis LA, Janowska-Wieczorek A. 2013. Enhancing the migration ability of mesenchymal stromal cells by targeting the SDF-1/CXCR4 axis. Biomed Res Int. 2013:561098. doi:10.1155/2013/561098.
   PubMed Web of Science ®Google Scholar
• Mehryab F, Rabbani S, Shahhosseini S, Shekari F, Fatahi Y, Baharvand H, et al. 2020. Exosomes as a next-generation drug delivery system: An update on drug loading approaches, characterization, and clinical application challenges. Acta Biomater. 113:42–62. doi:10.1016/j.actbio.2020.06.036.
   PubMed Web of Science ®Google Scholar
• Mills KM, Szczerkowski JLA, Habib SJ. 2017. WNT ligand presentation and reception: from the stem cell niche to tissue engineering. Open Biol. 7:8. doi:10.1098/rsob.170140.
   Web of Science ®Google Scholar
• Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. 2021. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 20(2):101–124. doi:10.1038/s41573-020-0090-8.
   PubMed Web of Science ®Google Scholar
• Moku G, Layek B, Trautman L, Putnam S, Panyam J, Prabha S. 2019. Improving payload capacity and anti-tumor efficacy of mesenchymal stem cells using TAT peptide functionalized polymeric nanoparticles. Cancers (Basel). 11(4). doi:10.3390/cancers11040491.
   Web of Science ®Google Scholar
• Mu H, Holm R. 2018. Solid lipid nanocarriers in drug delivery: characterization and design. Expert Opin Drug Deliv. 15(8):771–785. doi:10.1080/17425247.2018.1504018.
   PubMed Web of Science ®Google Scholar
• Muslimov AR, Timin AS, Bichaykina VR, Peltek OO, Karpov TE, Dubavik A, et al. 2020. Biomimetic drug delivery platforms based on mesenchymal stem cells impregnated with light-responsive submicron sized carriers. Biomater Sci. 8(4):1137–1147. doi:10.1039/c9bm00926d.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Mochida A, Choyke PL, Kobayashi H. 2016. Nanodrug delivery: is the enhanced permeability and retention effect sufficient for curing cancer? Bioconjug Chem. 27(10):2225–2238. doi:10.1021/acs.bioconjchem.6b00437.
   PubMed Web of Science ®Google Scholar
• Oh J, Son YS, Kim WH, Kwon OK, Kang BJ. 2021. Mesenchymal stem cells genetically engineered to express platelet-derived growth factor and heme oxygenase-1 ameliorate osteoarthritis in a canine model. J Orthop Surg Res. 16(1):43. doi:10.1186/s13018-020-02178-4.
   Web of Science ®Google Scholar
• Pang L, Zhang C, Qin J, Han L, Li R, Hong C, et al. 2017. A novel strategy to achieve effective drug delivery: exploit cells as carrier combined with nanoparticles. Drug Deliv. 24(1):83–91. doi:10.1080/10717544.2016.1230903.
   PubMed Web of Science ®Google Scholar
• Pascucci L, Cocce V, Bonomi A, Ami D, Ceccarelli P, Ciusani E, et al. 2014. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. J Control Release. 192:262–270. doi:10.1016/j.jconrel.2014.07.042.
   PubMed Web of Science ®Google Scholar
• Peng LH, Fung KP, Leung PC, Gao JQ. 2011. Genetically manipulated adult stem cells for wound healing. Drug Discov Today. 16(21–22):957–966. doi:10.1016/j.drudis.2011.07.009.
   Web of Science ®Google Scholar
• Peruzzaro ST, Andrews MMM, Al-Gharaibeh A, Pupiec O, Resk M, Story D, et al. 2019. Transplantation of mesenchymal stem cells genetically engineered to overexpress interleukin-10 promotes alternative inflammatory response in rat model of traumatic brain injury. J Neuroinflammation. 16(1):2. doi:10.1186/s12974-018-1383-2.
   Google Scholar
• Pessina A, Bonomi A, Coccè V, Invernici G, Navone S, Cavicchini L, et al. 2011. Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy. PLoS One. 6(12):e28321. doi:10.1371/journal.pone.0028321.
   PubMed Web of Science ®Google Scholar
• Poon W, Kingston BR, Ouyang B, Ngo W, Chan WCW. 2020. A framework for designing delivery systems. Nat Nanotechnol. 15(10):819–829. doi:10.1038/s41565-020-0759-5.
   PubMed Web of Science ®Google Scholar
• Preynat-Seauve O, Krause K-H. 2011. Stem cell sources for regenerative medicine: the immunological point of view. Semin Immunopathol. 33(6):519–524. doi:10.1007/s00281-011-0271-y.
   Web of Science ®Google Scholar
• Qi K, Li N, Zhang Z, Melino G. 2018. Tissue regeneration: The crosstalk between mesenchymal stem cells and immune response. Cell Immunol. 326:86–93. doi:10.1016/j.cellimm.2017.11.010.
   PubMed Web of Science ®Google Scholar
• Regmi S, Pathak S, Kim JO, Yong CS, Jeong JH. 2019. Mesenchymal stem cell therapy for the treatment of inflammatory diseases: challenges, opportunities, and future perspectives. Eur J Cell Biol. 98(5–8):151041. doi:10.1016/j.ejcb.2019.04.002.
   PubMed Web of Science ®Google Scholar
• Rejman J, Oberle V, Zuhorn IS, Hoekstra D. 2004. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J. 377(Pt 1):159–169.
   PubMed Web of Science ®Google Scholar
• Rhee KJ, Lee JI, Eom YW. 2015. Mesenchymal stem cell-mediated effects of tumor support or suppression. Int J Mol Sci. 16(12):30015–30033. doi:10.3390/ijms161226215.
   Web of Science ®Google Scholar
• Ruan J, Ji J, Song H, Qian Q, Wang K, Wang C, et al. 2012. Fluorescent magnetic nanoparticle-labeled mesenchymal stem cells for targeted imaging and hyperthermia therapy of in vivo gastric cancer. Nanoscale Res Lett. 7(1):309. doi:10.1186/1556-276x-7-309.
   Google Scholar
• Sadhukha T, O’Brien TD, Prabha S. 2014. Nano-engineered mesenchymal stem cells as targeted therapeutic carriers. J Control Release. 196:243–251. doi:10.1016/j.jconrel.2014.10.015.
   PubMed Web of Science ®Google Scholar
• Saeedi M, Eslamifar M, Khezri K, Dizaj SM. 2019. Applications of nanotechnology in drug delivery to the central nervous system. Biomed Pharmacother. 111:666–675. doi:10.1016/j.biopha.2018.12.133.
   PubMed Web of Science ®Google Scholar
• Salehi H, Al-Arag S, Middendorp E, Gergely C, Cuisinier F, Orti V. 2018. Dental pulp stem cells used to deliver the anticancer drug paclitaxel. Stem Cell Res Ther. 9(1):103. doi:10.1186/s13287-018-0831-3.
   Google Scholar
• Saulite L, Pleiko K, Popena I, Dapkute D, Rotomskis R, Riekstina U. 2018. Nanoparticle delivery to metastatic breast cancer cells by nanoengineered mesenchymal stem cells. Beilstein J Nanotechnol. 9:321–332. doi:10.3762/bjnano.9.32.
   PubMed Web of Science ®Google Scholar
• Severino P, da Silva CF, Andrade LN, de Lima Oliveira D, Campos J, Souto EB. 2019. Alginate nanoparticles for drug delivery and targeting. Curr Pharm Des. 25(11):1312–1334. doi:10.2174/1381612825666190425163424.
   PubMed Web of Science ®Google Scholar
• Sheyn D, Shapiro G, Tawackoli W, Jun DS, Koh Y, Kang KB, et al. 2016. PTH induces systemically administered mesenchymal stem cells to migrate to and regenerate spine injuries. Mol Ther. 24(2):318–330. doi:10.1038/mt.2015.211.
   Web of Science ®Google Scholar
• Song SY, Hong J, Go S, Lim S, Sohn HS, Kang M, et al. 2020. Interleukin-4 gene transfection and spheroid formation potentiate therapeutic efficacy of mesenchymal stem cells for osteoarthritis. Adv Healthc Mater. 9(5):e1901612. doi:10.1002/adhm.201901612.
   Web of Science ®Google Scholar
• Stephan MT, Moon JJ, Um SH, Bershteyn A, Irvine DJ. 2010. Therapeutic cell engineering with surface-conjugated synthetic nanoparticles. Nat Med. 16(9):1035–1041. doi:10.1038/nm.2198.
   PubMed Web of Science ®Google Scholar
• Sun L, Cui M, Wang Z, Feng X, Mao J, Chen P, et al. 2007. Mesenchymal stem cells modified with angiopoietin-1 improve remodeling in a rat model of acute myocardial infarction. Biochem Biophys Res Commun. 357(3):779–784. doi:10.1016/j.bbrc.2007.04.010.
   Web of Science ®Google Scholar
• Sun L, Fan X, Zhang L, Shi G, Aili M, Lu X, et al. 2014. Bone mesenchymal stem cell transplantation via four routes for the treatment of acute liver failure in rats. Int J Mol Med. 34(4):987–996. doi:10.3892/ijmm.2014.1890.
   PubMed Web of Science ®Google Scholar
• Suresh SC, Selvaraju V, Thirunavukkarasu M, Goldman JW, Husain A, Alexander Palesty J, et al. 2015. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium. Int J Cardiol. 201:517–528. doi:10.1016/j.ijcard.2015.08.117.
   PubMed Web of Science ®Google Scholar
• Teng CF, Jeng LB, Shyu WC. 2018. Role of insulin-like growth factor 1 receptor signaling in stem cell stemness and therapeutic efficacy. Cell Transplant. 27(9):1313–1319. doi:10.1177/0963689718779777.
   Web of Science ®Google Scholar
• Thanuja MY, Anupama C, Ranganath SH. 2018. Bioengineered cellular and cell membrane-derived vehicles for actively targeted drug delivery: So near and yet so far. Adv Drug Deliv Rev. 132:57–80. doi:10.1016/j.addr.2018.06.012.
   PubMed Web of Science ®Google Scholar
• Thanuja MY, Anupama C, Ranganath SH. 2018. Bioengineered cellular and cell membrane-derived vehicles for actively targeted drug delivery: so near and yet so far. Adv Drug Deliv Rev. 132:57–80. doi:10.1016/j.addr.2018.06.012.
   PubMed Web of Science ®Google Scholar
• Timin AS, Peltek OO, Zyuzin MV, Muslimov AR, Karpov TE, Epifanovskaya OS, et al. 2019. Safe and effective delivery of antitumor drug using mesenchymal stem cells impregnated with submicron carriers. ACS Appl Mater Interfaces. 11(14):13091–13104. doi:10.1021/acsami.8b22685.
   PubMed Web of Science ®Google Scholar
• Timin AS, Peltek OO, Zyuzin MV, Muslimov AR, Karpov TE, Epifanovskaya OS, et al. 2019. Safe and effective delivery of antitumor drug using mesenchymal stem cells impregnated with submicron carriers. ACS Appl Mater Interfaces. 11(14):13091–13104. doi:10.1021/acsami.8b22685.
   PubMed Web of Science ®Google Scholar
• Trams EG, Lauter CJ, Salem N, Jr., Heine U. 1981. Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim Biophys Acta. 645(1):63–70. doi:10.1016/0005-2736(81)90512-5.
   PubMed Web of Science ®Google Scholar
• Vader P, Mol EA, Pasterkamp G, Schiffelers RM. 2016. Extracellular vesicles for drug delivery. Adv Drug Deliv Rev. 106(Pt A):148–156. doi:10.1016/j.addr.2016.02.006.
   PubMed Web of Science ®Google Scholar
• Villa CH, Pan DC, Zaitsev S, Cines DB, Siegel DL, Muzykantov VR. 2015. Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrier. Ther Delivery. 6(7):795–826. doi:10.4155/tde.15.34.
   Google Scholar
• Wang M, Xin Y, Cao H, Li W, Hua Y, Webster TJ, et al. 2021. Recent advances in mesenchymal stem cell membrane-coated nanoparticles for enhanced drug delivery. Biomater Sci. 9(4):1088–1103. doi:10.1039/d0bm01164a.
   Web of Science ®Google Scholar
• Wang W, Lu K-J, Yu C-H, Huang Q-L, Du Y-Z. 2019. Nano-drug delivery systems in wound treatment and skin regeneration. J Nanobiotechnol. 17(1). doi:10.1186/s12951-019-0514-y.
   Google Scholar
• Wang WQ, Dong K, Zhou L, Jiao GH, Zhu CZ, Li WW, et al. 2015. IL-37b gene transfer enhances the therapeutic efficacy of mesenchumal stromal cells in DSS-induced colitis mice. Acta Pharmacol Sin. 36(11):1377–1387. doi:10.1038/aps.2015.51.
   PubMed Web of Science ®Google Scholar
• Wang X, Gao J, Ouyang X, Wang J, Sun X, Lv Y. 2018. Mesenchymal stem cells loaded with paclitaxel-poly(lactic-co-glycolic acid) nanoparticles for glioma-targeting therapy. Int J Nanomedicine. 13:5231–5248. doi:10.2147/ijn.S167142.
   PubMed Web of Science ®Google Scholar
• Wei JN, Cai F, Wang F, Wu XT, Liu L, Hong X, et al. 2016. Transplantation of CXCR4 overexpressed mesenchymal stem cells augments regeneration in degenerated intervertebral discs. DNA Cell Biol. 35(5):241–248. doi:10.1089/dna.2015.3118.
   Web of Science ®Google Scholar
• Wu HH, Zhou Y, Tabata Y, Gao JQ. 2019. Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic. J Control Release. 294:102–113. doi:10.1016/j.jconrel.2018.12.019.
   PubMed Web of Science ®Google Scholar
• Xu C, Feng Q, Yang H, Wang G, Huang L, Bai Q, et al. 2018. A light-triggered mesenchymal stem cell delivery system for photoacoustic imaging and chemo-photothermal therapy of triple negative breast cancer. Adv Sci (Weinh). 5(10):1800382. doi:10.1002/advs.201800382.
   PubMedGoogle Scholar
• Xu CH, Ye PJ, Zhou YC, He DX, Wei H, Yu CY. 2020. Cell membrane-camouflaged nanoparticles as drug carriers for cancer therapy. Acta Biomater. 105:1–14. doi:10.1016/j.actbio.2020.01.036.
   PubMed Web of Science ®Google Scholar
• Xu M, Asghar S, Dai S, Wang Y, Feng S, Jin L, et al. 2019. Mesenchymal stem cells-curcumin loaded chitosan nanoparticles hybrid vectors for tumor-tropic therapy. Int J Biol Macromol. 134:1002–1012. doi:10.1016/j.ijbiomac.2019.04.201.
   PubMed Web of Science ®Google Scholar
• Yang N, Ding Y, Zhang Y, Wang B, Zhao X, Cheng K, et al. 2018. Surface functionalization of polymeric nanoparticles with umbilical cord-derived mesenchymal stem cell membrane for tumor-targeted therapy. ACS Appl Mater Interfaces. 10(27):22963–22973. doi:10.1021/acsami.8b05363.
   PubMed Web of Science ®Google Scholar
• Yao S, Li X, Liu J, Sun Y, Wang Z, Jiang Y. 2017. Maximized nanodrug-loaded mesenchymal stem cells by a dual drug-loaded mode for the systemic treatment of metastatic lung cancer. Drug Deliv. 24(1):1372–1383. doi:10.1080/10717544.2017.1375580.
   PubMed Web of Science ®Google Scholar
• Zhai Y, Su J, Ran W, Zhang P, Yin Q, Zhang Z, et al. 2017. Preparation and application of cell membrane-camouflaged nanoparticles for cancer therapy. Theranostics. 7(10):2575–2592. doi:10.7150/thno.20118.
   PubMed Web of Science ®Google Scholar
• Zhao J, Vykoukal J, Abdelsalam M, Recio-Boiles A, Huang Q, Qiao Y, et al. 2014. Stem cell-mediated delivery of SPIO-loaded gold nanoparticles for the theranosis of liver injury and hepatocellular carcinoma. Nanotechnology. 25(40):405101. doi:10.1088/0957-4484/25/40/405101.
   PubMed Web of Science ®Google Scholar
• Zheng G, Ge M, Qiu G, Shu Q, Xu J. 2015. Mesenchymal stromal cells affect disease outcomes via macrophage polarization. Stem Cells Int. 2015:989473. doi:10.1155/2015/989473.
   PubMed Web of Science ®Google Scholar
• Zhou F, Teng F, Deng P, Meng N, Song Z, Feng R. 2018. Recent progress of nano-drug delivery system for liver cancer treatment. Anticancer Agents Med Chem. 17(14):1884–1897. doi:10.2174/1871520617666170713151149.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou W, Chen X, Wang Q, Li C, Chen Q, et al. 2020. Bone marrow mesenchymal stem cells-derived exosomes for penetrating and targeted chemotherapy of pancreatic cancer. Acta Pharm Sin B. 10(8):1563–1575. doi:10.1016/j.apsb.2019.11.013.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Ling X, Yang Y, Zhang J, Li Q, Niu X, et al. 2019. Embryonic stem cells-derived exosomes endowed with targeting properties as chemotherapeutics delivery vehicles for glioblastoma therapy. Adv Sci (Weinh). 6(6):1801899. doi:10.1002/advs.201801899.
   PubMedGoogle Scholar